EUVIMEDEUVIMED entdecken
Leitlinie

2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure

Writing Committee Members, Michelle M Kittleson, Khadijah Breathett, Boback Ziaeian, David Aguilar, Vanessa Blumer, Biykem Bozkurt, Rebecca L Diekemper, Michael P Dorsch, Paul A Heidenreich, Corrine Y Jurgens, Prateeti Khazanie und 2 weitere

Journal of the American College of Cardiology · 2024-09 · 84 (12) · 1123-1143

DOI: 10.1016/j.jacc.2024.05.014 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the American College of Cardiology, 2024-09. Verfasst von Writing Committee Members und 13 weiteren Autor:innen. Hauptthemen laut MEDLINE: Heart Failure, American Heart Association, Cardiology. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: Australia-China Council, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This document describes performance measures for heart failure that are appropriate for public reporting or pay-for-performance programs and is meant to serve as a focused update of the "2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures." The new performance measures are taken from the "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines" and are selected from the strongest recommendations (Class 1 or Class 3). In contrast, quality measures may not have as much evidence base and generally comprise metrics that might be useful for clinicians and health care organizations for quality improvement but are not yet appropriate for public reporting or pay-for-performance programs. New performance measures include optimal blood pressure control in patients with heart failure with preserved ejection fraction, the use of sodium-glucose cotransporter-2 inhibitors for patients with heart failure with reduced ejection fraction, and the use of guideline-directed medical therapy in hospitalized patients. New quality measures include the use of sodium-glucose cotransporter-2 inhibitors in patients with heart failure with mildly reduced and preserved ejection fraction, the optimization of guideline-directed medical therapy prior to intervention for chronic secondary severe mitral regurgitation, continuation of guideline-directed medical therapy for patients with heart failure with improved ejection fraction, identifying both known risks for cardiovascular disease and social determinants of health, patient-centered counseling regarding contraception and pregnancy risks for individuals with cardiomyopathy, and the need for a monoclonal protein screen to exclude light chain amyloidosis when interpreting a bone scintigraphy scan assessing for transthyretin cardiac amyloidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureAmerican Heart AssociationCardiologyHumansUnited StatesAdult

Stichwörter der Autor:innen

ACC/AHA Performance Measuresheart failureperformance measuresquality indicatorsquality measures

Förderung

  • Australia-China Council
  • American Heart Association

Zitieren

APA

Writing Committee Members, Kittleson, M. M., Breathett, K., Ziaeian, B., Aguilar, D., Blumer, V., Bozkurt, B., Diekemper, R. L., Dorsch, M. P., Heidenreich, P. A., Jurgens, C. Y., Khazanie, P., Koromia, G. A., & Van Spall, H. G. C. (2024). 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure. Journal of the American College of Cardiology, 84(12), 1123-1143. https://doi.org/10.1016/j.jacc.2024.05.014

Vancouver

Writing Committee Members, Kittleson MM, Breathett K, Ziaeian B, Aguilar D, Blumer V, et al. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure. Journal of the American College of Cardiology. 2024;84(12):1123-1143. doi:10.1016/j.jacc.2024.05.014

BibTeX
@article{WritingCommitteeMembers2024,
  author = {Writing Committee Members, Writing Committee Members and Kittleson, Michelle M and Breathett, Khadijah and Ziaeian, Boback and Aguilar, David and Blumer, Vanessa and Bozkurt, Biykem and Diekemper, Rebecca L and Dorsch, Michael P and Heidenreich, Paul A and Jurgens, Corrine Y and Khazanie, Prateeti and Koromia, George Augustine and Van Spall, Harriette G C},
  title = {2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure},
  journal = {Journal of the American College of Cardiology},
  year = {2024},
  volume = {84},
  number = {12},
  pages = {1123--1143},
  doi = {10.1016/j.jacc.2024.05.014}
}
Kostenlos starten →